Involvement of mitochondrial haplogroups in myocardial infarction and stroke: A case-control study in Castile and

Miriam Umbria1, Amanda Ramos1, Jennifer Caner1

  • 1Unitat d'Antropologia Biològica, Department BABVE, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain.

Mitochondrion
|December 21, 2017
PubMed

Insights

Mitochondrial DNA (mtDNA) haplogroup H is linked to increased myocardial infarction risk, while haplogroup J may offer protection against hypertension. These findings highlight genetic factors in cardiovascular disease development.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Mitochondrial Biology

Background:

  • Mitochondrial DNA (mtDNA) haplogroups are increasingly recognized for their potential role in disease pathogenesis.
  • Cardiovascular diseases (CVDs) represent a significant global health burden with complex etiological factors.

Purpose of the Study:

  • To investigate the association between specific mtDNA haplogroups and the risk of myocardial infarction (MI) and stroke.
  • To explore the relationship between mtDNA haplogroups and common cardiovascular risk factors, including hypertension.

Main Methods:

  • A matched case-control study design was employed.
  • Analysis focused on common mtDNA haplogroups and their correlation with MI, stroke, and hypertension.
  • Statistical analysis included odds ratios (OR) and confidence intervals (CI) to assess risk and protective effects.

Main Results:

  • Mitochondrial DNA haplogroup H was identified as a significant susceptibility risk factor for myocardial infarction (p=0.001; OR=2.379).
  • Mitochondrial DNA haplogroup J demonstrated a potential beneficial role in mitigating the risk of hypertension (p=0.019; OR=0.348).

Conclusions:

  • Specific mtDNA haplogroups, such as H and J, may influence individual susceptibility to cardiovascular diseases.
  • Understanding these genetic variations could aid in predicting cardiovascular disease risk across diverse populations.
  • Differences in energy efficiency between mtDNA haplogroups might underlie their impact on cardiovascular health.

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.3K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
559
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
9
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
294
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
456